Budesonide
Budesonide is a potent local-acting glucocorticoid corticosteroid with high anti-inflammatory activity but low systemic availability due to extensive first-pass metabolism. It is widely used for maintenance therapy in asthma, allergic rhinitis, and localized inflammatory bowel diseases.
Dosage by Body Weight
Dosage varies significantly based on formulation, age, and severity of the condition. For asthma maintenance, standard nebulization in children is 0.25 mg to 0.5 mg twice daily. Oral capsules for Crohn's disease are typically dosed at 9 mg once daily in the morning for adults. Always consult a healthcare professional as budesonide is a prescription-only medication.
- Body Weight
- Below 5 kg
- Dose
- Not established
- Frequency
- Use only if prescribed by a specialist
- Tracking Notes
- Safety and efficacy in infants under 12 months have not been established. Dosing is not standard.
- Body Weight
- 5-7 kg
- Dose
- Individualized by specialist
- Frequency
- Usually 1 to 2 times daily (inhalation)
- Tracking Notes
- Corticosteroid dosing in infants is based on clinical severity and age, not strictly on body weight. Strict medical supervision required.
- Body Weight
- 8-10 kg
- Dose
- 0.25 mg (Nebulizer Suspension)
- Frequency
- Once or twice daily
- Tracking Notes
- For pediatric asthma nebulization. Oral capsules are not suitable for this weight/age group.
- Body Weight
- 11-15 kg
- Dose
- 0.25 mg to 0.5 mg (Nebulizer Suspension)
- Frequency
- Once or twice daily
- Tracking Notes
- Inhalation suspension dose is determined by clinical response and disease severity rather than weight.
- Body Weight
- 16-20 kg
- Dose
- 0.25 mg to 0.5 mg (Nebulizer Suspension)
- Frequency
- Once or twice daily
- Tracking Notes
- May be increased up to 1 mg daily in divided doses under medical supervision if the asthma is severe.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not established | Use only if prescribed by a specialist | Safety and efficacy in infants under 12 months have not been established. Dosing is not standard. |
| 5-7 kg | Individualized by specialist | Usually 1 to 2 times daily (inhalation) | Corticosteroid dosing in infants is based on clinical severity and age, not strictly on body weight. Strict medical supervision required. |
| 8-10 kg | 0.25 mg (Nebulizer Suspension) | Once or twice daily | For pediatric asthma nebulization. Oral capsules are not suitable for this weight/age group. |
| 11-15 kg | 0.25 mg to 0.5 mg (Nebulizer Suspension) | Once or twice daily | Inhalation suspension dose is determined by clinical response and disease severity rather than weight. |
| 16-20 kg | 0.25 mg to 0.5 mg (Nebulizer Suspension) | Once or twice daily | May be increased up to 1 mg daily in divided doses under medical supervision if the asthma is severe. |
Formulation
Purpose
Used to reduce inflammation in chronic asthma, allergic rhinitis, nasal polyps, Crohn's disease, and ulcerative colitis.
Generic Name
BudesonideBranded Drug Names
Budesonide is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.